Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Oct;63(10):4185–4187. doi: 10.1128/iai.63.10.4185-4187.1995

Preferential induction of septic arthritis and mortality by superantigen-producing staphylococci.

T Bremell 1, A Tarkowski 1
PMCID: PMC173591  PMID: 7558340

Abstract

Staphylococcal enterotoxins A through D (SEA through SED) and toxic shock syndrome toxin-1 display superantigen properties, i.e., they stimulate a great fraction of T cells expressing certain T-cell receptor V beta sequences. Using a newly established rat model of septic Staphylococcus aureus arthritis, we have recently shown that an S. aureus strain producing SEA showed marked arthritogenic properties. In the present study we decided to employ another five S. aureus strains, each one producing a distinct exotoxin. Almost all rats injected with superantigen-producing strains developed arthritis. In contrast, only 20% of rats injected with an S. aureus strain lacking superantigen production displayed mild and transient arthritis. Mortality was preferentially induced among the rats inoculated with the S. aureus strains producing SEB and SED. This study emphasizes that superantigen production is an important virulence factor in the development of septic S. aureus arthritis. Differences concerning mortality between staphylococcal strains producing different exotoxins may be dependent on the degree of activation of the immune system.

Full Text

The Full Text of this article is available as a PDF (173.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdelnour A., Bremell T., Holmdahl R., Tarkowski A. Clonal expansion of T lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin-1-producing staphylococci. Eur J Immunol. 1994 May;24(5):1161–1166. doi: 10.1002/eji.1830240523. [DOI] [PubMed] [Google Scholar]
  2. Abdelnour A., Bremell T., Holmdahl R., Tarkowski A. Role of T lymphocytes in experimental Staphylococcus aureus arthritis. Scand J Immunol. 1994 Apr;39(4):403–408. doi: 10.1111/j.1365-3083.1994.tb03392.x. [DOI] [PubMed] [Google Scholar]
  3. Abdelnour A., Bremell T., Tarkowski A. Toxic shock syndrome toxin 1 contributes to the arthritogenicity of Staphylococcus aureus. J Infect Dis. 1994 Jul;170(1):94–99. doi: 10.1093/infdis/170.1.94. [DOI] [PubMed] [Google Scholar]
  4. Bergdoll M. S., Borja C. R., Avena R. M. Identification of a new enterotoxin as enterotoxin C. J Bacteriol. 1965 Nov;90(5):1481–1485. doi: 10.1128/jb.90.5.1481-1485.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bremell T., Abdelnour A., Tarkowski A. Histopathological and serological progression of experimental Staphylococcus aureus arthritis. Infect Immun. 1992 Jul;60(7):2976–2985. doi: 10.1128/iai.60.7.2976-2985.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bremell T., Lange S., Holmdahl R., Rydén C., Hansson G. K., Tarkowski A. Immunopathological features of rat Staphylococcus aureus arthritis. Infect Immun. 1994 Jun;62(6):2334–2344. doi: 10.1128/iai.62.6.2334-2344.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bremell T., Lange S., Svensson L., Jennische E., Gröndahl K., Carlsten H., Tarkowski A. Outbreak of spontaneous staphylococcal arthritis and osteitis in mice. Arthritis Rheum. 1990 Nov;33(11):1739–1744. doi: 10.1002/art.1780331120. [DOI] [PubMed] [Google Scholar]
  8. Bremell T., Lange S., Yacoub A., Rydén C., Tarkowski A. Experimental Staphylococcus aureus arthritis in mice. Infect Immun. 1991 Aug;59(8):2615–2623. doi: 10.1128/iai.59.8.2615-2623.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. CASMAN E. P., BERGDOLL M. S., ROBINSON J. DESIGNATION OF STAPHYLOCOCCAL EXTEROTOXINS. J Bacteriol. 1963 Mar;85:715–716. doi: 10.1128/jb.85.3.715-716.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Casman E. P., Bennett R. W., Dorsey A. E., Issa J. A. Identification of a fourth staphylococcal enterotoxin, enterotoxin D. J Bacteriol. 1967 Dec;94(6):1875–1882. doi: 10.1128/jb.94.6.1875-1882.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Elwing H., Nygren H. Diffusion in gel-enzyme linked immunosorbent assay (DIG-ELISA): a simple method for quantitation of class-specific antibodies. J Immunol Methods. 1979;31(1-2):101–107. doi: 10.1016/0022-1759(79)90290-4. [DOI] [PubMed] [Google Scholar]
  12. Green J., Schotland S., Sella Z., Kleeman C. R. Interleukin-6 attenuates agonist-mediated calcium mobilization in murine osteoblastic cells. J Clin Invest. 1994 Jun;93(6):2340–2350. doi: 10.1172/JCI117239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Novick R. Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus. Virology. 1967 Sep;33(1):155–166. doi: 10.1016/0042-6822(67)90105-5. [DOI] [PubMed] [Google Scholar]
  14. Patti J. M., Bremell T., Krajewska-Pietrasik D., Abdelnour A., Tarkowski A., Rydén C., Hök M. The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infect Immun. 1994 Jan;62(1):152–161. doi: 10.1128/iai.62.1.152-161.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Schlievert P. M. Role of superantigens in human disease. J Infect Dis. 1993 May;167(5):997–1002. doi: 10.1093/infdis/167.5.997. [DOI] [PubMed] [Google Scholar]
  16. Tarkowski A., Czerkinsky C., Nilsson L. A. Detection of IgG rheumatoid factor secreting cells in autoimmune MRL/1 mice: a kinetic study. Clin Exp Immunol. 1984 Oct;58(1):7–12. [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES